Processa Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that…

Biotechnology
US, Hanover [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Processa Pharmaceuticals, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Processa Pharmaceuticals, Inc. can't present revenue by segment

End of PCSA's Analysis
CIK: 1533743 CUSIP: 74275C205 ISIN: US74275C3043 LEI: - UEI: -
Secondary Listings
PCSA has no secondary listings inside our databases.